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ABSTRACT 
Anaplastic astrocytoma (AA) is a diffusely infiltrating malignant, astrocytic, primary brain 
tumour with a peak incidence between 40 to 50 years of age is a leading cause of cancer 
death. Though cancer chemotherapy is highly effective in many cancers, but side-effects of 
chemotherapy are severe in many patients like myelosuppression, anorexia, weight loss, 
mucositis, fatigue, nausea, vomiting and diarrhoea. It appears that side effects of 
chemotherapy are manifestations of aggravated Tridosha as Raktadushti (vitiated blood). 
Therefore, present case study was undertaken to find effectiveness of Ayurvedic medication 
as an adjuvant or co-therapy in the management of oligoastrocytoma as well as in 
minimizing the side effect of chemo-radiotherapy. A female patient of age 40 years with 
brain cancer (clinically diagnosed case of anaplastic oligoastrocytoma grade 3rd) undergoing 
oral chemotherapy by irnocam 150 mg, avastin 400mg for 6 cycle and radiotherapy was 
taken. Patient was given classical Ayurvedic formulation of Rasa sindur 50mg+ 
Abhrakbhasma 250mg+ Vachachurna 500mg+ Panchamritalauha guggulu 250mg BD with 
honey, Shatavarighrita 5gm BD with milk, Jyotishmatitaila 5 drops BD with Bataasha and 
cap SNEC30 (liquid curcumin capsules). After the completion of 6th cycle there were very 
encouraging results observed with negligible side effects, improvement in all chief 
complaints, general health condition and quality of life of the patient. Ayurvedic medication 
appears to have significant effect on reducing side effect of chemo-radiotherapy and 
improving quality of life in the patient of brain cancer (oligoastrocytoma). 
KEYWORDS: Oligoastrocytoma, Tridosha, Raktadushti, Chemo-Radiotherapy, Quality of life, 
Rasa sindur, Abhrakbhasma, Vachachurna, Panchamritalauha guggulu, Shatavarighrita, 
Jyotishmatitaila. 
INTRODUCTION 
 Anaplastic astrocytoma (AA) is a diffusely 
infiltrating, malignant, astrocytic, primary brain 
tumour with a median age of onset of 40 to 50 years. 
AA constitutes 4% of all malignant CNS tumours and 
10% of all gliomas[1]. The survival of patients with AA 
varies depending upon molecular pathology. With 
conventional treatment, median overall survival 
(MOS) and 5 year survival rates are 3 years and 28%, 
respectively. Whereas very few children are 
diagnosed with Oligoastrocytoma. In modern 
medicine[2] chemotherapy and radiotherapy is the 
main treatment modalities of cancer treatment. A 
considerable number of patients have to go through 
distressing treatments like chemotherapy and 
radiotherapy. Chemotherapy and radiotherapy are 
considered an effective way to help cancer survivors 
but chemotherapy drugs are highly toxic and produce 
myelosuppression and some serious side effects like 
nausea, vomiting, diarrhoea, mucositis, alopecia, 
constipation etc[3]. Whereas radiation therapy though 
administered locally, can produce systemic side 
effects such as fatigue, anorexia, nausea, vomiting, 
alteration in the taste, sleep disturbance, headache, 
anaemia, dry skin, constipation etc.[4] These arrays of 
side effects have a devastating effect on the quality of 
life of cancer survivors. As modern science and 
medical advancement provide the rationale for the 
integration of various Alternative and 
Complementary Medicine to promote healing, health 
and longevity, present case study was undertaken to 
find effectiveness of Ayurvedic medication as a 
adjuvant or co-therapy in the management of 
oligoastrocytoma as well as in minimizing the side 
effect of chemo-radiotherapy[5]. 
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Case Report 
The present case study is a successful 
Ayurvedic management as a co-therapy in a case of 
anaplastic oligoastrocytoma. A 40-year-old Hindu 
female patient having history of anaplastic 
oligoastrocytoma since 6 years presented with 
complaints of weakness in right upper limb, difficulty 
in speaking, decreased appetite, weight loss, anaemia 
and fatigue. Her MRI brain revealed that she was a 
known case of anaplastic oligoastrocytoma grade III, 
in postoperative status, she was advised 
radiotherapy and chemotherapy by her oncologist. 
She had completed her radiotherapy cycle of 52 days 
(from 19-11-2018 to 09-01-2019). Then she was 
advised for chemotherapy (6 cycles from 24-02-2019 
to 03-06-2019). But patient was not willing to take 
chemotherapy due to fear of side-effects such 
alopecia, severe nausea, vomiting, lack of appetite 
and fatigue. Post-radiotherapy the patient reported 
to National Institute of Ayurveda, Jaipur for 
Ayurvedic medication on 27/02/2019. This is a 
single case study and consent was taken from the 
patient and study was in accordance with ICH-GCP 
guidelines. 
Table 1: Showing complaints of patient 
Sr.no Chief complaints duration 
1 Weakness in right upper limb 15 days 
2 Difficulty in speech 15 days 
3. Generalised weakness 6 month 
4 anorexia 4 month 
5 Weight loss 4 month 
Associated complaints: none 
Past history – K/c/o–oligoastrocytoma operated in 
October 2018 
Table 2: Showing medication taken by patient 
(chemotherapy drugs for 6 cycles from 24-02-
2019 to 03-06-2019) 
S.no Name of medicine Dosage/frequency 
1 Irnocam 150mg 
2 Avastin 400mg 
3 Neukine 300mcg 
 
 
 
 
 
 
 
Table 3: Personal history 
Appetite good 
Sleep disturbed 
Micturition 4-5 times a day 
Bowl Twice a day 
Addiction  Tea 2 times a day 
On physical examination 
Weight - 60kg 
Height - 160cm 
BMI - 23.4 kg/m2 
Blood pressure - Lying right arm 140/90mmHg 
Sitting right arm130/90mmHg 
Pulse- 82bpm, regular; Respirations 20/min 
Thyroid: non palpable 
Lungs: clear to auscultation 
Heart: Rate and rhythm regular, no murmurs or 
gallops 
Vascular assessment: no carotid bruits, femoral 
popliteal and dorsalis pedis pulses2+ bilaterally 
Neurological assessment: Diminished power and 
motor activity in right upper and lower limb 
Astavidhapariksha 
Nadi– Kaphaja, Guru nadi 
Mala– Saama, Shushkamala, Alpapravritti 
Mutra– Samyakpravriti 
Jihwa – Shwetaliptata 
Sparsha- Snigdha 
Shabda- Gambheer 
Drik- Prakrat 
Akriti–Samanya 
General Examination 
Consciousness – Conscious 
General appearance –Normal 
Built – Moderate 
Pallor – present 
Icterus – Absent 
Cyanosis- Absent 
Clubbing – Absent 
Oedema – Absent 
Lymphadenopathy – Absent 
Gait – Normal 
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Table 4: Therapeutic intervention 
S.no Contents 
1.Rasa Sindure Parad and Gandhaka 
2. Abhraka Bhasm Purified Abhraka 
Vacha Churna Vacha 
Panchamrita Lauha Guggulu Shuddhaparad, Shuddhagandhaka, Raupyabhasma, 
Abhrakabhasma, Swarnamakshikbhasma, Lauhabhasma, 
Shudhaguggulu 
Cap. Snec 30 Liquid Curcumin (Arbro pharmaceutical product) 
Jyotishmati Taila Tilataila processed with Jyotishmati 
Shatavari Ghrita Shatavari, Goghrita 
Table 5: Follow-up and outcomes 
Subjective finding (chief complaints)  B.T  A.T 
Weakness in right upper limb Present Mild present 
Difficulty in speech Present Mild present 
Generalised weakness Present Absent 
Anorexia Present Absent 
Weight loss Present Absent 
Subjective findings (chemotherapy side effect)   
Nausea & vomiting Present Absent 
Fatigue Present Mild present 
Alopecia Absent Absent 
Xerostomia Present Absent 
Tastelessness Present Absent 
Weight loss Present Absent 
Assessment criteria 
Table 6: QQL in Oligoastrocytoma (Brain Cancer)[6] 
Assessment of the effect of therapy on quality of life was carried out on the basis of FACIT 
Questionnaires {Functional Assessment of Chronic Illness Therapy or Cancer Therapy (FACT)}. The general 
cancer specific questionnaire consists of five domains: 
 Physical 
 Social/Family 
 Emotional 
 Functional Well-Being 
 Additional Concerns 
QOL Parameters 27/02/2019 14/03/2019 29/03/2019 13/04/2019 
physical Well-being 20/28 15/28 13/28 10/28 
Social/Family Well-Being 19/28 17/28 15/28 15/28 
Emotional Well-Being 19/28 17/28 15/28 12/28 
Functional* Well-Being 4/28 7/28 11/28 11/28 
Additional Concerns 54/92 45/92 40/92 40/92 
 116/204 101/204 94/204 88/204 
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In the above table deceasing score is showing improvement in the physical, social/family, emotional 
well-being along with additional concerns while increasing score showing improvement in functional well-
being in the patient with the treatment.  
DISCUSSION 
Chemotherapy medicines produce side-effects like diarrhoea, loss of appetite, weakness, vomiting, 
constipation, fever, stomatitis, burning sensation, weight loss, alopecia, myelosupression and affects the quality 
life of patients. Through Ayurvedic perspective, it appears that side effects of chemotherapy are the 
manifestations of aggravated Tridosha under the group of disorders as Raktadushti and as mentioned in 
Ayurveda classics.[7] Shoola is the sign of aggravated Vatadosha, Daha (burning sensation) Davathu (acid 
regurgitation), Mukhapaka (stomatitis), Payupaka (urethritis), Gudapaka (proctitis) etc. are the sign and 
symptoms of aggravated Pitta dosha, Aruchi, Chhardi,Vibandh etc., are the sign of aggravated Kaphadosha. 
Chemotherapy drugs also vitiates Jaṭharagni causes Annavaha Srotodushti Lakshana viz., Aruchi, 
Anannabhilashanam, Chhardi etc. The principle behind selection of these drugs and Tridosh-shamaka regimen 
was to restore and support functioning of gastro-intestinal system, reducing pain and promotes strength to 
patient. 
Formulations Karma (Pharmacological Effect) 
Abhrakabhasma Ushnavirya, Balya-rasayan effect, Ojovardhak, Tridosh-shamak, Raktavardhak, Yogvahi, 
Agnivardhaka 
Ras sindur  Ushnavirya, Balya, Rasayan, Rakta-shodhaka 
 Behave as a Protease inhibitor by inhibiting the proteolysis of BSA by trypsin 
proves its anticancer activity.[8] 
 This Ayurvedic drug also shows antioxidant property 
Vachachurna Ayurvedic properties- Ushnavirya, Katutikta rasa, Vacha has a special potency 
(Prabhava) as a nervine tonic (Medhya), Vacha is Agnivardhaka, Mala-
Mutravishodhaka, Lekhana 
Chemical constituents  
1. The ethanolic extract of Acorus calamus has anti-proliferative and 
immunosuppressive properties. This extract causes the tumour necrosis which 
inhibits the proliferation of mitogen, antigen stimulated peripheral blood 
mononuclear cells in humans, nitric oxide and interleukins[9] 
2. Anticancer activity of Acorus calamus rhizomes was evaluated, hydroalcohlic extract 
of Acorus calamus rhizome showed anti-proliferative activity on anticancer cell.[10] 
3. Methanolic extract of Acorus calamus showed analgesic and anti- inflammatory 
effect. 
Panchamrit 
Lauha Gugullu 
Act as antiseptic, anti-bacterial, astringent, anti-spasmodic, anti-inflammatory agent. 
Abhrakbhasma which is one of the ingredients is known for treatment of various 
chronic diseases. 
Roupyabhasma known for its Vatashamak property acting on kidney, brain and nerves 
has analgesic activity and useful in many condition like pain, neuralgias, inflammation, 
anxiety, convulsion. 
Memory loss etc. 
Swarnamakshik Bhasma is indicated in the effective management of Mandagni Anidra, 
Apasmara, Pandu etc. 
Loha Bhasma is useful in treatment of various conditions like Pandu (anaemia), 
Shotha (oedema). 
So Panchamrit Loha Guggulu has analgesic and anti-inflammatory properties. 
It improves blood circulation to the brain and act on brain, nerves, blood vessels, 
heart muscles, bones and joints. It is commonly used in the treatment of mental 
disorders, symptoms associated with nervine weakness, neuralgia, neuritis etc. 
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Jyotishmati[11] oil 
 
 
 
 
 
Cap. Snec30 
 
Shatavarighrit 
This oil extracted from Celastrus paniculatus is known to have effect on central 
nervous system. It has reported activities like anti-inflammatory, anti-fatigue, 
analgesic, sedative, laxative, nervine tonic.[12] 
Its chief component curcumin derived from rhizome of Curcuma longa has potent 
Antioxidant activity- The water soluble protein turmerin- a polypeptide act as an 
antioxidant 
Anti-inflammatory activity[13] 
Anti -cancer activity- curcumin has anti-cancer activity due to free radical scavenging 
activity, blocking of NFkB, anti-mutagenic activity and antioxidant activity.[14] 
Shatavari (Asparagus recemosus Wild) is the famous drug of Balya Gaṇa which 
promotes strength to patient and has adaptogenic and anti-oxidant property. 
All above drugs are potent digestive, 
absorbent, Raktapittashamaka, Tridosh-shamaka and 
carminative and having Rasayan effect. The principle 
behind selection of these drugs having Tridosh-
shamak and Agnivardhaka properties was to restore 
and support functioning of gastro-intestinal system 
and promotes strength to patient. 
Aggravated Tridosha is the fundamental basis 
for management of cancer and preventing 
chemotherapy side-effects and the Rasayan drugs 
which are used in above treatment have the ability to 
reduce imbalances related to Tridosha. The case 
study concluded that, Rasayana drugs and Tridosh-
shamak regimen is an effective adjuvant therapy in 
protecting the patient from the disease and adverse 
effect of chemotherapy drug in cancer. As, the recent 
researches have shown that a number of Rasayan 
dravyas mentioned in Ayurveda classics have proven 
anti-cancer properties.[15] This Ayurvedic medication 
certainly improves the strength of patient, quality of 
life of the cancer patient, and may enhance the life 
expectancy. 
Over the past several decades, cancer 
treatment includes multimodal treatment regimens 
(surgery, chemotherapy, radiation) and palliative 
therapy administered by various routes and 
innovative procedures have added longevity and 
symptomatic relief in a large number of cancer 
survivors. However, the quality of life of these 
survivors during and even after the treatment period 
is pitiable. At this juncture, following the concept of 
integrative oncology drugs like Haridra, Rasa sindur, 
Abhrak bhasma, Shatavarighrit etc. By virtue of its 
anti-cancer potential, it can offer a lot of aid in 
improving and augmenting the quality of life of 
cancer patients. 
Experimental data of this case study suggest 
that these drugs act at each stage of promotion and 
progression of oligoastrocytoma and prevention of 
chemo-radiotherapy side effects as well. So in this 
case study we can conclude that above drugs can be 
used in following aspects: 
 
1. To supplement anti-cancer treatment 
2. To reduce side effects of chemotherapy and 
radiotherapy. 
3. To reduce pain and complications 
CONCLUSION 
Besides Shatavarighrit, Jyotishmati oil have 
chemo-radiotherapy side effects preventive potential. 
Due to shortcomings of conventional chemotherapy 
in the advanced stages of cancer and its adverse 
effects, Haridra (curcumine), Rasa sindur and 
Abhrakbhasma with a defined molecular target 
approach will play an important role in future in 
palliative treatment. Role of these drugs as a chemo-
radiotherapy side effects reducing agent will Prevent 
oligoastrocytoma (cancer) and its side effects and 
thus the number of deaths caused by this disease.  
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